Lineage Cell Therapeutics, Inc. (LCTX)
NYSEAMERICAN: LCTX · Real-Time Price · USD
1.000
-0.030 (-2.91%)
Oct 30, 2026, 4:00 PM EDT - Market closed
Lineage Cell Therapeutics Employees
As of December 31, 2025, Lineage Cell Therapeutics had 77 total employees, including 70 full-time and 7 part-time employees. The number of employees did not change compared to the previous year. That makes Lineage Cell Therapeutics the 32,952nd largest employer in the world and 4,291st in the United States.
Employees
77
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$169,909
Profits / Employee
-$418,961
Market Cap
252.91M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 77 | 0 | - | 72 | 5 |
| Dec 31, 2024 | 77 | 2 | 2.67% | 70 | 7 |
| Dec 31, 2023 | 75 | -3 | -3.85% | 68 | 7 |
| Dec 31, 2022 | 78 | 17 | 27.87% | 70 | 8 |
| Dec 31, 2021 | 61 | 6 | 10.91% | 57 | 4 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Abeona Therapeutics | 226 |
| Fate Therapeutics | 161 |
| Lyell Immunopharma | 161 |
| Cabaletta Bio | 158 |
| Ocugen | 116 |
| Larimar Therapeutics | 71 |
| Lexeo Therapeutics | 63 |
| Immuneering | 57 |
LCTX News
- 1 day ago - Lineage Cell provides an update on ReSonance program for hearing loss - TheFly
- 1 day ago - Lineage Provides Update on ReSonance® Program for Hearing Loss - Business Wire
- 7 weeks ago - Lineage Cell announces issuance of patent underlying AlloSCOPE 5D platform - TheFly
- 7 weeks ago - Lineage Cell Therapeutics Announces Issuance of Patent Underlying Its AlloSCOPE™ 5D Manufacturing Platform - Business Wire
- 2 months ago - Lineage Cell Therapeutics management to meet with B. Riley - TheFly
- 2 months ago - Lineage Cell Therapeutics Earnings Call Transcript: Q2 2026 - Transcripts
- 2 months ago - Lineage Cell Therapeutics Earnings release: Q2 2026 - Filings
- 2 months ago - Lineage Cell Therapeutics Quarterly report: Q2 2026 - Filings